Company Information & Drug Savings for Shionogi Pharma Medications

Shionogi is a Japanese pharmaceutical company with US operations in infectious diseases, pain management, and CNS disorders. The company developed cefiderocol (Fetroja) for multidrug-resistant gram-negative infections and baloxavir (Xofluza) for influenza. Shionogi’s infectious disease expertise addresses antimicrobial resistance and emerging viral threats.